The view
As of 13 November 2026, Williams-Sonoma closed at $254.05, a change of +33.8% over the past year. The close sits +17.4% from its 200-day average and 54% above its 52-week low, so the stock trades well up its yearly range. No intrinsic value figure is available in this reading, so the price cannot be set against the platform's Intrinsic Value model here. The published 21-session view leans up, with an expected return of +0.08%. The published 63-session view leans up only barely, with an expected return of +0.2%, close to flat.
Next month: why the model view is positive
The 21-session lean is upward but thin. The expected return is +0.08%, while the published probability of a rise is only 21%. That pairing points to a lopsided distribution: most outcomes are small declines and a minority are larger gains. Strong momentum and quality readings support the upward side. Against it stand a strong risk-off market regime and short-sale volume at percentile 98 in its sector, which signals heavy crowding. Across 200 past situations like today's, the median return over the following 21-session horizon was +0.9%, and 54% of them rose. That history is not a forecast. It agrees with a mild upward median but does not echo the low probability of a rise.
Next 3 months: model view positive
Over the 63-session horizon the published view is essentially flat with a slight upward tilt at +0.2%, inside a wide band from −26% to +26.4%. It points the same way as the 21-session view at +0.08% but carries less conviction. That fits a risk-off backdrop pressing against the company's momentum and quality strengths. Macro sensitivity also ranks high among large US companies, which adds exposure to the direction of the overall market. The past situations like today's did better: their median return over the 63-session horizon was +3.6%, and 61% of them rose. That history leans more clearly upward than the model. This suggests the model weighs the regime and the crowding more heavily than the history alone does.
The long term
The long-term case rests on the quality of the business rather than on any valuation discount. Earnings trade at 23.42 times, at percentile 73 in its sector, and book value at 12.58 times, so the stock is not inexpensive against its peers. Against that, return on equity is 55%, the Piotroski score is 6 of nine, revenue grew +6.7%, and operating cash flow reached $1.61B. Balance sheet health and earnings quality sit at the highest readings of the company's own five years. Past situations like today's, which are history rather than a forecast, returned a median +18.6% over the following year, and 70% of them rose. The regime and the crowding hold back the near-term views. The longer case is carried by quality and cash generation.
How sure we are
On this name, 59% of 283 matured 21-session forecasts matched the direction. That is above the base rate of about half across all names, which gives the near-term view moderate weight. The historical comparison rests on 200 past situations, a reasonable sample. Those situations were matched on only seven measures, not on the 552 features computed today. The bands are wide: −18.2% to +18.4% on the 21-session horizon and −26% to +26.4% on the 63-session horizon, both far larger than the central expectations. The longer horizons lean on history and fundamentals without a published intrinsic value, so every horizon here carries limited certainty.